chrisvoncsefalvay/vaers-outcomes huggingface dataset:
she reported on 18Dec2020 got vaccine later that day tested positive; she reported on 18Dec2020 got vaccine later that day tested positive; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received the 1st dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose on 18Dec2020 for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. She reported on 18Dec2020 got vaccine later that day tested positive with outcome of unknown. She asked can she still receive the 2nd dose of the vaccine or should she repeat the vaccination series.  The patient underwent lab tests and procedures which included Sars-Cov-2 test: positive on 18Dec2020.  Information on the lot/batch number has been requested.; Sender's Comments: Based on available information, a possible contributory role of the subject product, BNT162B2 vaccine, cannot be excluded for the reported events due to temporal relationship.  There is limited information provided in this report.  Additional information is needed to better assess the case, including complete medical history, diagnostics, counteractive treatment measures and concomitant medications. This case will be reassessed once additional information is available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
March 18 I had a covid contact and was positive did not know it. March 19 I received my 2nd vaccine. March 20 I became sick intense Covid head pain, joint pain and brain fog. My condition continued by May 25, was put on TDI and have been out of work. Daily head pain some as long as 12 hours, joint pain, problems walking at times ( I have fallen many times), speach problems at times and memory and brain fog issues still continue. October 30, I received my booster shot the the head pain and joint pain has increased.  I have been to the covid clinic and two neurologist and have an appointment with covid clinic on November 16. I have a case number with Moderna #MOD21-161037. The DOH asked me to file with you. I have tried many mirgraine treatments with no relief. I am currently on Gabapentin 300mg  they are treating me with seizer medication now.
Minor rash after first dose, faded away. Rash came back after 2nd dose, has lasted a week and feels as though it is not getting better. Rash was located in 3 hot spots (left and right arms under arm/near armpit, and lower stomach). Rash has slowly spread and has not shown improvement with benedryl/loratadine and cortosone over last 4-5 days.
2 1/2 x 3 inches, Knot on inner right thigh erythematous, warm to touch, painful, pruritic, no arthralgia/fever, 4 year immunizations given 1 day prior at another clinic. DTap, MMR right leg, IPV left leg.
On 1/19/21 noticed a cluster of red bumps on arm around 7 pm, applied benadryl and went to bed. Woke up the next morning to a circle of red in the area. Treated with more benadryl and ice. The following day it was not as red but the spot was 3 inches wide X 4 inches long, went to the Doctors office who measured it. The following day the color was less red, more skin color - was warm to the touch and had little bumps on the skin outside of the original circle. The following day the discoloration was gone and the bumps were smaller.
patient was given an expired vaccine the date the vaccine expired was on 7/8/22. Today's date is 7/15/22 there where no adverse affects.
Information has been received from a registered nurse referring to a patient of unknown age and gender. There was no pertinent medical history, concomitant medication or drug allergies/drug reactions reported. On 06-NOV-2015, the patient was vaccinated with ZOSTAVAX (0.65 ml, Lot#L024997, expiration date: 06-OCT-2016), which was improperly stored for 44 days (Incorrect product storage). The outcome was unknown. This is one of several reports received from the same reporter. Additional information has been requested.
extreme shortness of breath after one week and admitted to hospital with blood clots in both lungs and a collapsed lobe in right lung within two weeks
Varicella Vaccine breakthrough, diagnosed with varicella 8/4/06 in our office. Had 12 lesions on arm chest. No fever.
when moves arm there is pain; bruise on her arm 3 inches below the injection site; touches the injection site, it hurts; Arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was sore), CONTUSION (bruise on her arm 3 inches below the injection site), VACCINATION SITE PAIN (touches the injection site, it hurts) and PAIN IN EXTREMITY (when moves arm there is pain) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     The patient had no allergies. The patient's medical history included high blood pressure and high cholesterol.  The patient's past medical history included Diabetes and Acid reflux (esophageal). Concomitant products included LOSARTAN, AMLODIPINE, PRAVASTATIN, METFORMIN, OMEPRAZOLE, TRIAMTERENE and HYDROCHLOROTHIAZIDE for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (Arm was sore). On 30-Jan-2021, the patient experienced CONTUSION (bruise on her arm 3 inches below the injection site) and VACCINATION SITE PAIN (touches the injection site, it hurts). On an unknown date, the patient experienced PAIN IN EXTREMITY (when moves arm there is pain). At the time of the report, PAIN IN EXTREMITY (Arm was sore) had resolved and CONTUSION (bruise on her arm 3 inches below the injection site), VACCINATION SITE PAIN (touches the injection site, it hurts) and PAIN IN EXTREMITY (when moves arm there is pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication was not reported. The patient was scheduled for her second vaccine on 22-Feb-2021.
Administered adult dose of 1.0 cc Havrix Hepatitis A vaccine to Patient. Who should have received 0.5 cc dose.
blood clot in the lungs; covid-19; This is a solicited report from a non-Pfizer sponsored program,  received from a contactable consumer based on information received by Pfizer from Bristol-Myers Squibb(manufacturer control number: US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-065486), license party for apixaban.  This 64-year-old male patient was involved in a patient support program. The patient (patient ID: redacted) received APIXABAN. The report describes a case of PULMONARY THROMBOSIS (blood clot in the lungs) and COVID-19. Co-suspect products included Covid-19 Vaccine for an unknown indication. On an unknown date, the patient started APIXABAN (unknown route), (unspecified dose and frequency). On an unknown date, the patient experienced PULMONARY THROMBOSIS (seriousness criteria hospitalization and medically significant) and COVID-19 (seriousness criterion hospitalization). The patient was treated with Surgery for Pulmonary thrombosis. The action taken with APIXABAN(Unknown) was unknown. At the time of the report, PULMONARY THROMBOSIS and COVID-19 outcome was unknown. Patient reported he got the Covid-19 shot and then got Covid-19, and got a blood clot. Patient was then sent to emergency and had surgery to get the blood clot taken out of his lungs. For APIXABAN(Unknown), the reporter did not provide any causality assessments. The primary reporter was the consumer. The indication of apixaban therapy was unknown.  Medical Evaluation Comment: This patient was hospitalized due to COVID 19 and Blood clot in lungs after receiving apixaban study therapy. Considering the anticoagulant nature of suspect therapy and the infective nature, mode of transmission and current pandemic situation due to COVID 19, a role of study therapy in the event COVID-19 is considered unlikely. Blood clot in lungs could be likely secondary to COVID-19 infection, hence not related to suspect therapy.  Causality assessment about apixaban for events 'thrombosis pulmonary, COVID-19' was not related as per Company (Bristol-Myers Squibb) and was not provided as per reporter.; Sender's Comments: Based on the compatible temporal association, there was a reasonable possibility that the vaccination with BNT162B2 played a contributory role in triggering the onset of the reported events. Conversely, the company does not attribute the reported events to study drug apixaban.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Moderna COVID-19 Vaccine-     Diarrhea, nausea,  fever/99.1
Received two dose regimen of Pfizer vaccine on 3/27/21 and 4/17/21.   During annual physical in June 2021 an elevated TSH reading was identified during bloodwork.  Follow up bloodwork identified that I have Hashimoto's Disease (hypothyroidism).  No known family history of this.  Symptoms of slight tiredness and low resting heart rate.
Pain and swelling at site within 30 minutes of injection, nausea, vomiting, severe headache.
1. Unusual behavior, poorly responsive, anxious/ irritable x few hours. 2. Rash distal to injection both LEs 3. Low grade fever.
This spontaneous report was received from a pharmacist referring to unspecified patients of unknown age and gender. The patients' concurrent conditions and medical history were not provided. On unknown dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 (dose, lot number, expiration date and anatomical location were not reported) which were stored in a temperature of 31F during 45 days. No previous temperature excursion was reported. Other suspect therapies included an sterile diluent (lot #: K026419, expiration date: 19-OCT-2017, Lot #: L041248, expiration date: 27-JAN-2018), which were exposed with the same conditions. Concomitant therapies were not provided. No adverse events were reported. No product quality complaint was involved. This is one of several reports coming from the same source. Additional information has been requested.
Patient (driver of vehicle) passed out shortly after leaving the vaccination lane, while proceeding to the post administration area. Patient was involved in a 5 vehicle in the post administration area. Patient was assessed on scene by emergency unit and transported by emergency unit to local ER for further evaluation.
pt recv vax 10JUN96 & 14JUN96 pt devel a non-irritated rash on face;pt was eval by MD who determined that pt exp was d/t mosquito bites;f/u from MD ofc revealed dx was incorrect;
Pain in left arm at 0200 woke me up and kept me awake.  By noon on 1/12 I had fever that got to 101, but responded to Tylenol.  Ongoing chills.  Fatigue, headache.  All common side effects of vaccine per the education given at the time of the shot.  I did go to work on 1/12 but ended up leaving around 1000.  Fever, chills resolved around 0500 on 1/13.  Fatigue, headache resolved around 1300 on 1/13.  This is my 2nd baby, due June 7th 2021.  All normal pregnancy so far.  Recently had 20 week anatomical ultrasound that showed baby has slightly large tummy, doc will check for gestational diabetes at 28 weeks, did not express major concern.
The adverse event was not due to the vaccinee, but I got COVID on Dec 30th, 2022. I saw the doctor to get Paxlovid. I had Cough, weakness and fever.
Headache around 6pm with nausea I took ibu and went to bed early. Tuesday  still bad headache getting worse and then I noticed swollen lymph nodes under left armpit. Wednesday left arm nodes really swollen and still headache so called primary dr. Took ibu and went to dentist appointment at 1pm and still had headache and blood pressure was 219/109.  Since the vaccine I`m not getting blood pressure  under control and i`ve never had high blood pressure. Please help?
Initial information received on 19-Oct-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 years old male patient who experienced swelling, redness and heat coming from the arm at injection site, while he received vaccine FLUZONE. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 17-Oct-2018, the patient received a  0.5 ml once dose of suspect FLUZONE lot UI983AA, expiry date- 30-Jun-2019 via intramuscular route in the left deltoid at 06:00 PM. On an unknown date, patient developed a non-serious swelling, redness and heat coming from the arm at injection site (vaccination site inflammation) following the administration of FLUZONE. (Other relevant tests included No lab test.) Final diagnosis was swelling, redness and heat coming from the arm at injection site. The patient was treated with BENADRYL ALLERGY and PREDNISONE. The patient outcome is reported as Unknown for swelling, redness and heat coming from the arm at injection site.
Seventeen year old patient came to pharmacy on 9/2/22 in with mother requesting new bivalent booster. Patient was accidentally administered the Moderna Bivalent Booster. Patient sat for observation for 15 minutes after vaccination with no adverse reactions. Patient and mother were informed of the error within 10 minutes of vaccination, and told to report any adverse reactions and events to VAERS and V-safe. Pharmacy to follow up with patient tomorrow 9/3/22.
Received DTaP 2 days ago to upper right thigh. Parent noticed increased redness and swelling to right thigh the following day. Patient afebrile and acting fine. Area of 2.5inches x 2.5inches of redness, non-tender.
Apparently no distress, playful, digital temp by mo 98.4; erythematous rash on trunk & face on awaking on AM 25JUL91; Recvd 3rd DTP/HIB on 24JUL91; no reddness @ either inject site; Mo gave Panadol;
headaches; This case was reported by a consumer via interactive digital media and described the occurrence of headache in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced headache. On an unknown date, the outcome of the headache was not recovered/not resolved.   It was unknown if the reporter considered the headache to be related to Shingrix.  Additional details were reported as follows: The age at vaccination was not reported.  The age group was not reported but was captured as adult as per vaccine indication.  The reporter asked how long do headaches from the Shingrix vaccine last.
Feeling tired; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feeling tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (Feeling tired). At the time of the report, FATIGUE (Feeling tired) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.   This case was linked to MOD-2021-060265 (Patient Link).
FAINTING (Fainting, Syncope) LOW BLOOD PRESSURE (Low blood pressure, Hypotension) VOMITING (Vomiting, Vomiting) SHAKY (Shaking, Tremor) CHILLS (Chills, Chills) HEADACHE (Headache, Headache) FEVER (Fever, Pyrexia) NAUSEA (Nausea, Nausea) PAIN AT INJECTION SITE (Injection site pain, Injection site pain) This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2 .s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-MAR-2021, the subject experienced fainting. On 11-MAR-2021, the patient experienced low blood pressure and pain at injection site. On 12-MAR-2021, the patient experienced vomiting, shaky, chills, headache, fever and nausea. It was reported that, the patient had bad reaction within few minutes after receiving the vaccine low blood pressure and fainting. Later, the patient was taken into stretcher, monitored vitals onsite and 45 minutes later, she drove home. The patient felt ok last night. At the time of this report, the patient was shaky, had chills, fever, nausea, vomiting, headache and injection site pain. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fainting, and low blood pressure on MAR-2021, was recovering from shaky, chills, nausea, and vomiting, had not recovered from headache, and pain at injection site, and the outcome of fever was not reported. The reporter considered the causality between covid-19 vaccine ad26.cov2.s and fainting, low blood pressure, shaky, has chills, fever, nausea, vomiting, headache, injection site pain as related. Company causality between covid-19 vaccine ad26.cov2.s and fainting, low blood pressure, shaky, has chills, fever, nausea, vomiting, headache, injection site pain was possible. This report was serious (Other Medically Important Condition).
Information has been received from a 20 year old female RN who was vaccinated with the 1st dose of Hep-B vaccine recombinant (yeast). Subsequently, the pt experienced soreness at the injection site and fever. Subsequently, the pt recovered from the soreness at the injection site and fever. On 8/17/01, the pt was vaccinated with the 2nd dose of Hep-B vaccine recombinant (yeast). On approx. 8/22/01, approx. 5 to 10 days, post vax, the pt noted that her arm had started to disintegrate and that her muscle was deteriorating. She reported that it looked like the flesh on her arm was burnt. She was not hospitalized but has lost considerable strength in her arm. She cannot lift or pull as much as she had been able to previously. The area continues to become larger with no resolution. The pt reported that she was on exercises to try to strengthen her arm. She also reported that she previously took allergy shots with no reactions but she had not taken them for over 1 year. Soreness at injection site, fever muscular atrophy, muscular weakness and skin or skin appendage condition were considered to be disabling. Additional information has been requested. Additional info has been received from a physician. The physician reported that the pt developed some inflammation and induration beginning on approximately 8/22/01 (five to ten days) after receiving her second dose of hep b vaccine recombinant. The inflammation and induration disappeared and had been replaced by muscle atrophy. The muscles sunken in an area by about 1cm by 2 1/2cm in the posterior deltoid area. On 1/12/02 the pt's hep B surface anti-body titer was 24. The physician reported that the pt had received some physical therapy but no other medication at this time. The pt was still experiencing muscle weakness. Additional information has been received from the physician. The physician reported that he believed that the patient needed physical theapy. Additional information has been received from the physician. The physician reported that the patient received her second dose of hepatitis B vaccine recombinant (yeast) on 08/17/01 and subsequently developed inflammation in the area which became erythematous, indurated and tender. He reported that she had no sterile abscess or other acute problem. However, subsequently after the inflammation had resolved the patient developed significant atrophy in the posterior left deltoid. The physician reported that she did have some physical therapy which he did seem to help her and therefore that was stopped. She has persisted in having atrophy in the area and weakness in the half centimeters or more. There is weakness in the area secondary to the loss of muscle tissue. The physician reported that the patient's titer was good and that he thought that the patient would need ongoing physical therapy. The physician also reported that the patient's liver panel on 01/21/02 was "normal". No additional information is expected.
This patient went to various locations throughout County from March 1, 2023 through July 12, 2023 and received 8 COVID vaccines in that time span.  this individual sign up utilizing various addresses, telephone numbers, and emails with same name and DOB.
Woke up on 02Jan with a red and swollen, slightly itchy, left 4th finger. Redness progressed to left hand, and arm. Generalized red rash noted in groin and abdomen. Slight headache and nausea.; Woke up on 02Jan with a red and swollen, slightly itchy, left 4th finger. Redness progressed to left hand, and arm. Generalized red rash noted in groin and abdomen. Slight headache and nausea.; Woke up on 02Jan with a red and swollen, slightly itchy, left 4th finger. Redness progressed to left hand, and arm. Generalized red rash noted in groin and abdomen. Slight headache and nausea.; Woke up on 02Jan with a red and swollen, slightly itchy, left 4th finger. Redness progressed to left hand, and arm. Generalized red rash noted in groin and abdomen. Slight headache and nausea; Woke up on 02Jan with a red and swollen, slightly itchy, left 4th finger. Redness progressed to left hand, and arm. Generalized red rash noted in groin and abdomen. Slight headache and nausea.; Woke up on 02Jan with a red and swollen, slightly itchy, left 4th finger. Redness progressed to left hand, and arm. Generalized red rash noted in groin and abdomen. Slight headache and nausea.; This is a spontaneous report from a contactable consumer, the patient.  A 68 -year-old elderly female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EL0142), via an unspecified route of administration in the left arm on 29Dec2020 at 02:30 PM, (at the age of 68 -years-old) as a single dose, dose number=1 for COVID-19 vaccination.  Medical history included hypothyroidism and osteopenia. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications included levothyroxin and citalopram within 2 weeks of the vaccination.  The patient did not  receive  any other vaccine within 4 weeks prior to the vaccine. On 02Jan2021, the patient woke up with a red and swollen, slightly itchy, left 4th finger, redness progressed to left hand, and arm, generalized red rash noted in groin and abdomen, slight headache and nausea. The patient was treated for red and swollen, slightly itchy, left 4th finger, redness progressed to left hand, and arm, generalized red rash noted in groin and abdomen, slight headache and nausea with diphenhydramine (BENADRYL) 50 mg x 1. The clinical outcome of red and swollen, slightly itchy, left 4th finger, redness progressed to left hand, and arm, generalized red rash noted in groin and abdomen, slight headache and nausea was recovering.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.